Dr. Welgus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
907 Forest Lake Crt
Ballwin, MO 63021Phone+1 314-412-6990
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Dermatology, 1978 - 1981- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1977 - 1978
- Washington University in St. Louis School of MedicineClass of 1977
Certifications & Licensure
MI State Medical License 1999 - 2026- American Board of Dermatology Dermatology
Clinical Trials
- TSN2898-201 Safety and Efficacy of TSN2898 in the Treatment of Acne Vulgaris Start of enrollment: 2016 Jun 01
- Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis Start of enrollment: 2017 Dec 11
- Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis Start of enrollment: 2018 Dec 18
Publications & Presentations
PubMed
- 54 citationsTrial of Roflumilast Cream for Chronic Plaque PsoriasisMark Lebwohl, Kim A. Papp, Linda Stein Gold, Melinda Gooderham, Leon H Kircik
The New England Journal of Medicine. 2020-07-15 - 20 citationsInterstitial collagenase activity stimulates the formation of actin rings and ruffled membranes in mouse marrow osteoclasts.L.S. Holliday, Howard G. Welgus, J. Hanna, Beth S. Lee, Ming Lu
Calcified Tissue International. 2003-01-15 - 34 citationsN-glycan structures of matrix metalloproteinase-1 derived from human fibroblasts and from HT-1080 fibrosarcoma cells.Juhani Saarinen, Howard G. Welgus, Catherine A. Flizar, Nisse Kalkkinen, Jari Helin
European Journal of Biochemistry. 2001-12-25
Journal Articles
- Trial of Roflumilast Cream for Chronic Plaque PsoriasisLeon H Kircik, Steven E Kempers, Howard Welgus, The New England Journal of Medicine
Authored Content
- Trial of Roflumilast Cream for Chronic Plaque PsoriasisJuly 2020
Press Mentions
Arcutis Appoints Patrick Burnett, M.D., Ph.D., FAAD, as Chief Medical OfficerJuly 27th, 2020
Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercialization Partnership for Novel Immune-Mediated Dermatology Therapy Using SHR0302January 5th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
